Prediction of the development of Alzheimer disease in patients with mild cognitive impairment

Japanese Journal of Geriatrics

Volumn 47, Issue 2, 2010, Pages 147-152

  Kume, Kazumasa ^a   Hanyu, Haruo ^a   Sato, Tomohiko ^a   Hirao, Kentaro ^a   Kanetaka, Hidekazu ^a   Shimizu, Soichiro ^a   Sakurai, Hirofumi ^a   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Awareness of memory deficits; Mild cognitive impairment; MRI; SPECT

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77953529596     PISSN: 03009173     EISSN: None     Source Type: Journal    
DOI: 10.3143/geriatrics.47.147     Document Type: Article

References (24)

1. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al.: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
2. Hanyu H, Sakurai H, Hirao K, Shimizu S, Iwamoto T: Unawareness of memory deficits depending on cerebral perfusion pattern in mild cognitive impairment. J Am Geriatr Soc 2007; 55: 470-471.
3. Hanyu H, Sakurai H, Hirao K, Sato T, Iwamoto T: Difference in practice effects depending on cerebral perfusion pattern in mild cognitive impairment. Int J Geriatr Psychiatry 2008; 23: 111-112.
4. Japanese Source.
5. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
6. Highes CP, Berg L, Danzieger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
7. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975; 12: 189-198.
8. Sheikh JI, Yesavage JA: Geriatric depression scale (GDS), recent evidence and development of a shorter version. Clin Gerontologist 1986; 5: 165-173.
9. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's disease and normal aging. Am J Radiol 1987; 149: 351-356.
10. Hirata Y, Matsuda H, Nemoto K, Ohnishi T, Hirao K, yamashita F, et al.: Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 2005; 382: 269-274.
11. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238-1248.
12. Japanese Source.
13. Japanese Source.
14. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al.: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-1403.
15. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al.: Hippocampal and entorhinal atrophy in mild cognitive impairment. Prediction of Alzheimer disease. Neurology 2007; 68: 828-836.
16. Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, et al.: MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008; 70: 512-520.
17. Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, et al.: The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005; 28: 1014-1021.
18. Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron J-C: Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003; 60: 1374-1377.
19. Okamura N, Arai H, Maruyama M, Higuchi M, Matsui T, Tanji H, et al.: Combined analysis of CSF tau levels and [123I] iodoamphetamine SPECT in mild cognitive impairment: Implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 2002; 159: 474-476.
20. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, et al.: Combinde 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2007; 27: 24-31.
21. Drzezga A, Grimmer T, Riemenschneider M, Lautenshlager N, Siebner H, Alexopoulus P, et al.: Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET. J Nucl Med 2005; 46: 1625-1632.
22. Maruyama M, Matsui T, Tanji H, Nemoto M, Tomita N, Ootsuki M, et al.: Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment. Implications for 2 major pathways. Arch Neurol 2004; 61: 716-720.
23. Hanyu H, Sato T, Takasaki A, Akai T, Iwamoto T: Frontal lobe dysfunctions in subjects with mild cognitive impairment. J Neurol 2009 May 9 [Epub ahead of print].
24. Petersen RC, Thomas RG, Grundman M, Bennet D, Doody R, Ferris S, et al.: Vitamine E and donepezil for the treatment of mild cognitive impairment. New Engl J Med 2005; 35: 2379-2388.